Compounded Medication – Prescription Only

This product is a compounded nasal spray formulation containing selank and dispensed only pursuant to a valid prescription issued by a licensed healthcare provider. Selank is a synthetic peptide structurally derived from a fragment of the naturally occurring tetrapeptide tuftsin. In compounding practice, intranasal peptide formulations may be prescribed when a provider determines that individualized formulation, concentration, or delivery considerations are clinically appropriate for a specific patient. This product is not available for self-selection and may only be dispensed following provider authorization.

Compounded medications are not approved by the U.S. Food and Drug Administration (FDA). The FDA does not evaluate compounded formulations for safety, effectiveness, or quality. Compounding is performed by a state-licensed pharmacy pursuant to a patient-specific prescription. This page provides general, non-therapeutic information for educational and compliance purposes only. It does not describe intended use, therapeutic benefit, neurologic effects, anxiolytic effects, cognitive outcomes, or expected clinical results.

General Scientific Information (Non-Therapeutic)

Selank has been referenced in scientific literature for its molecular structure and classification as a synthetic peptide studied in laboratory and research environments. Research has examined its interaction with peptide receptors and neurochemical pathways under controlled conditions. Descriptions of biochemical characteristics or peptide classification are provided solely for general scientific context. No claims are made regarding safety, effectiveness, mood regulation, anxiety reduction, cognitive enhancement, or suitability for any particular condition.

Contraindications

Selank nasal spray should not be used in individuals who have a known hypersensitivity or allergy to selank, peptide-based compounds, or any component of the compounded formulation; have experienced prior adverse reactions to intranasal peptide preparations; have significant nasal pathology that may interfere with intranasal administration; or are unable to tolerate nasal spray formulations as determined by the prescribing healthcare provider. Use in pregnant or breastfeeding individuals should occur only if a licensed healthcare provider determines that potential risks and benefits have been carefully evaluated.

Warnings and Precautions

Intranasal peptide formulations may cause local nasal irritation or systemic effects. Caution is advised in individuals with chronic nasal conditions, recent nasal surgery, or those receiving medications that affect central nervous system pathways. Patients should inform their healthcare provider of all medical conditions, medications, and supplements prior to use. This product should be used only as prescribed by a licensed healthcare provider.

Potential Side Effects

Reported side effects associated with intranasal peptide formulations may include nasal irritation, congestion, sneezing, headache, dizziness, fatigue, or mild gastrointestinal discomfort. Serious adverse reactions are uncommon but may occur. Patients should seek medical attention if they experience signs of a severe allergic reaction or unexpected systemic symptoms.